G Proteins and Modulation of Insulin Secretion
暂无分享,去创建一个
[1] L. Birnbaumer,et al. G proteins in signal transduction. , 1990, Annual review of pharmacology and toxicology.
[2] L. Olson,et al. Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit. , 1989, The Journal of biological chemistry.
[3] E. Seaquist,et al. Pertussis Toxin–Sensitive G Protein Mediation of PGE2 Inhibition of cAMP Metabolism and Phasic Glucose-Induced Insulin Secretion in HIT Cells , 1989, Diabetes.
[4] H. Bourne,et al. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.
[5] P. Casey,et al. G proteins control diverse pathways of transmembrane signaling 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] E. Van Obberghen,et al. Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. , 1989, The Journal of biological chemistry.
[7] C. Wollheim,et al. GTP-dependent inhibition of insulin secretion by epinephrine in permeabilized RINm5F cells. Lack of correlation between insulin secretion and cyclic AMP levels. , 1988, The Journal of biological chemistry.
[8] S. Metz. Epinephrine Impairs Insulin Release by a Mechanism Distal to Calcium Mobilization: Similarity to Lipoxygenase Inhibitors , 1988, Diabetes.
[9] E. Helmreich,et al. Structural and functional relationships of guanosine triphosphate binding proteins. , 1988, Current topics in cellular regulation.
[10] J. Moss,et al. ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. , 1988, Advances in enzymology and related areas of molecular biology.
[11] R. Robertson,et al. Receptor-Mediated Adenylate Cyclase—Coupled Mechanism for PGE2 Inhibition of Insulin Secretion in HIT Cells , 1987, Diabetes.
[12] A. Couvineau,et al. Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterization. , 1987, Endocrinology.
[13] G. Greenberg,et al. Galanin Inhibits Insulin Secretion and Induces Hyperglycemia in Dogs , 1985, Diabetes.
[14] C. Wollheim,et al. Islet cyclic AMP levels are not lowered during alpha 2-adrenergic inhibition of insulin release. , 1984, The Journal of biological chemistry.
[15] T. Katada,et al. ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. , 1982, The Journal of biological chemistry.
[16] T. Katada,et al. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Katada,et al. Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase. , 1981, The Journal of biological chemistry.
[18] H. Bourne,et al. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Cherksey,et al. Preponderance of β-Adrenergic Binding Sites in Pancreatic Islet Cells of the Rat , 1981, Diabetes.
[20] A. Gilman,et al. Biochemical properties of hormone-sensitive adenylate cyclase. , 1980, Annual review of biochemistry.
[21] H. Bourne,et al. Genetic analysis of hormone-sensitive adenylate cyclase. , 1980, Advances in cyclic nucleotide research.
[22] T. Katada,et al. Effect of in vivo pretreatment of rats with a new protein purified from Bordetella pertussis on in vitro secretion of insulin: role of calcium. , 1979, Endocrinology.
[23] G. Weir,et al. Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. , 1979, The Journal of clinical investigation.
[24] T. Katada,et al. Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. , 1979, The Journal of biological chemistry.
[25] D. Cassel,et al. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Katada,et al. Perfusion of the pancreas isolated from pertussis-sensitized rats: potentiation of insulin secretory responses due to beta-adrenergic stimulation. , 1977, Endocrinology.
[27] M. Ui,et al. Potentiation of the adrenergic beta-receptor-mediated insulin secretion in pertussis-sensitized rats. , 1975, Endocrinology.
[28] D. Porte,et al. Inhibition of in vivo insulin secretion by prostaglandin E1. , 1974, The Journal of clinical investigation.
[29] I. Burr,et al. Effects of prostaglandin E1 and of epinephrine on the dynamics of insulin release in vitro. , 1974, Endocrinology.
[30] D. Porte,et al. The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. , 1973, The Journal of clinical investigation.
[31] L. Birnbaumer,et al. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. , 1971, The Journal of biological chemistry.
[32] D. Porte. Beta Adrenergic Stimulation of Insulin Release in Man , 1967, Diabetes.
[33] D. Porte. A receptor mechanism for the inhibition of insulin release by epinephrine in man. , 1967, The Journal of clinical investigation.
[34] D. Porte,et al. The effect of epinephrine on immunoreactive insulin levels in man. , 1966, The Journal of clinical investigation.
[35] P. J. Randle,et al. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. , 1964, The Biochemical journal.